Mevalotin
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
188 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypercholesterolemia | D006937 | — | — | — | 5 | 9 | 9 | 6 | 29 |
| Dyslipidemias | D050171 | — | — | 1 | 3 | 3 | 6 | 5 | 17 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 6 | 3 | 1 | 4 | 2 | 16 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | 1 | 6 | 4 | 4 | 15 |
| Hyperlipidemias | D006949 | EFO_0003774 | E78.5 | 1 | 1 | 4 | 6 | 1 | 13 |
| Coronary artery disease | D003324 | — | I25.1 | — | 1 | — | 6 | 4 | 11 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 1 | 2 | 3 | 5 | 11 |
| Hyperlipoproteinemias | D006951 | — | — | 1 | 1 | 4 | 5 | — | 11 |
| Syndrome | D013577 | — | — | 2 | 4 | — | 2 | 2 | 9 |
| Coronary disease | D003327 | — | — | — | 2 | 1 | 5 | 1 | 9 |
Show 47 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | 1 | 3 | 1 | — | 1 | 4 |
| Hyperlipoproteinemia type ii | D006938 | EFO_0004911 | E78.00 | — | 1 | 3 | — | — | 4 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 2 | 1 | — | — | 4 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | — | 3 | 1 | — | — | 4 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | 3 | 1 | — | — | 4 |
| Pre-eclampsia | D011225 | EFO_0000668 | O14 | 1 | 1 | 1 | — | — | 3 |
| Carcinoma | D002277 | — | C80.0 | — | 2 | 1 | — | — | 3 |
| Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | 1 | — | 1 | — | — | 2 |
| Vascular diseases | D014652 | EFO_0004264 | I77 | — | — | 1 | — | 1 | 2 |
| Arthrogryposis | D001176 | EFO_0003857 | Q74.3 | — | 1 | 1 | — | — | 2 |
Show 18 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 3 | 2 | — | — | 1 | 5 |
| Fibrosis | D005355 | — | — | 1 | 4 | — | — | — | 4 |
| Progeria | D011371 | EFO_0000671 | E34.8 | — | 3 | — | — | — | 3 |
| Neoplasms | D009369 | — | C80 | 2 | 2 | — | — | — | 2 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 1 | 1 | — | — | 1 | 2 |
| Megakaryoblastic leukemia acute | D007947 | — | C94.2 | 1 | 1 | — | — | 1 | 2 |
| Monocytic leukemia acute | D007948 | — | — | 1 | 1 | — | — | 1 | 2 |
| Myelomonocytic leukemia acute | D015479 | — | C92.5 | 1 | 1 | — | — | 1 | 2 |
| Myeloid leukemia | D007951 | — | C92 | 1 | 1 | — | — | 1 | 2 |
| Erythroblastic leukemia acute | D004915 | EFO_1001257 | C94.0 | 1 | 1 | — | — | 1 | 2 |
Show 21 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 13 | — | — | — | — | 13 |
| Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 3 | — | — | — | — | 3 |
| Arthritis | D001168 | EFO_0005856 | M05-M14 | 3 | — | — | — | — | 3 |
| Acute kidney injury | D058186 | — | N17 | 1 | — | — | — | 1 | 2 |
| Drug interactions | D004347 | — | — | 2 | — | — | — | — | 2 |
| Therapeutic equivalency | D013810 | — | — | 2 | — | — | — | — | 2 |
| Hiv seronegativity | D018023 | — | — | 1 | — | — | — | — | 1 |
| Nephrotic syndrome | D009404 | EFO_0004255 | N04 | 1 | — | — | — | — | 1 |
| Nephrosis | D009401 | — | — | 1 | — | — | — | — | 1 |
| Hepatitis c | D006526 | — | B19.2 | 1 | — | — | — | — | 1 |
Show 9 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Prostatic neoplasms | D011471 | — | C61 | — | — | — | — | 1 | 1 |
| Postpartum depression | D019052 | EFO_0007453 | F53.0 | — | — | — | — | 1 | 1 |
| Myelodysplastic syndromes | D009190 | — | D46 | — | — | — | — | 1 | 1 |
| Myeloproliferative disorders | D009196 | — | D47.1 | — | — | — | — | 1 | 1 |
| Myelomonocytic leukemia chronic | D015477 | — | C93.1 | — | — | — | — | 1 | 1 |
| Anemia | D000740 | EFO_0004272 | D64.9 | — | — | — | — | 1 | 1 |
| Myelodysplastic-myeloproliferative diseases | D054437 | — | — | — | — | — | — | 1 | 1 |
| Myelomonocytic leukemia juvenile | D054429 | — | C93.3 | — | — | — | — | 1 | 1 |
| Preleukemia | D011289 | — | — | — | — | — | — | 1 | 1 |
| Refractory anemia with excess of blasts | D000754 | — | D46.2 | — | — | — | — | 1 | 1 |
Show 8 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
367 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use